Sponsor:
Stephan Busque
Code:
NCT03591302
Conditions
Immune Tolerance
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Hematopoietic cell transplantation
Total Lymphoid irradiation
Brief summary:
Conditions
Immune Tolerance
Study ID
NCT03591302
Start date
Feb 2, 2024
Status verified date
Jun, 2026
Completion date
Oct 1, 2028
Anticipated
Primary completion date
Oct 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
25 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Immune tolerance, Kidney transplantation
Interventions
Hematopoietic cell transplantation
Total Lymphoid irradiation
Primary outcome measure
Central contacts
Locations
Stanford University Medical Center
Recruiting
Palo Alto, California, United States, 94304
Contacts
Principal Investigator:
Everett Meyer, MD
Sponsor
Stephan Busque
Last update posted
Jul 1, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Stephan Busque on 2026-07-01.